Integrated analysis of genomic and epigenomic alterations in circulating tumor DNA in patients with colorectal cancer and advanced adenoma
Not Applicable
- Conditions
- Colorectal cancer and advanced adenoma.
- Registration Number
- JPRN-UMIN000037765
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 501
Inclusion Criteria
Not provided
Exclusion Criteria
1.Have previous history of cancer, including colorectal cancer, within 10 years before the enrollment. 2.Have previous history of colorectal advanced adenoma within 3 months before the enrollment. 3.Are suspected to have other malignancies by chest-abdomen-pelvic contrast CT within 60 days before the enrollment. 4.Are pregnant. 5.Are judged by the study doctor to be ineligible for the study for any other reason.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive rate of LUNAR assay in advanced colorectal adenoma and stage 0-2 colorectal cancer.
- Secondary Outcome Measures
Name Time Method